transposon-manipulated allogeneic car-t therapy for b-all
Published 3 years ago • 139 plays • Length 5:35Download video MP4
Download video MP3
Similar videos
-
0:54
ucartcs1: a novel allogeneic car-t therapy for myeloma
-
3:10
universal car-t therapy for t-all
-
1:33
patient selection for car-t in all
-
0:51
developing universal car-t therapies for t-all
-
1:49
a novel subcutaneous car-t therapy for the treatment of hematological malignancies
-
1:55
exploring first-line car-t therapy for the treatment of dlbcl
-
0:37
hot topics in car t-cell therapy for all
-
2:30
generating car-t cells with piggybac transposons
-
1:59
the latest advances in car-t therapy for b-all
-
0:57
new indications for car-t therapies in hematological malignancies
-
1:56
car t-cell therapy for relapsed all with cns involvement
-
3:08
current car-t treatments for t-all and next steps
-
4:10
car t-cell therapy for all
-
7:36
star t-cell therapy for r/r b-cell all
-
1:08
the benefits of car-t therapy in 2l over 3l in r/r dlbcl
-
2:48
outcomes of autosct, allosct & car-t cell therapy in patients with tp53-altered mcl
-
3:38
mechanisms of resistance to car-t in all: t-cell fitness, antigen loss and immunological rejection
-
0:59
identifying molecular markers for the prediction of icaht in patients receiving car t-cell therapy
-
3:31
the role of lymphodepletion in car t-cell therapy: current knowledge & the need for personalization